<DOC>
	<DOCNO>NCT02220790</DOCNO>
	<brief_summary>The purpose study 1 ) define operate characteristic fungal biomarker assay pediatric patient high-risk develop invasive candidiasis , 2 ) determine change fungal biomarker assay result child develop invasive candidiasis , 3 ) create biobank blood sample pediatric patient high-risk invasive candidiasis invasive candidiasis future test fungal biomarker assay development new fungal biomarker assay . The study assemble prospective cohort pediatric patient high-risk develop invasive candidiasis . Blood sample biomarker test obtained time patient clinical indication blood culture attainment . Additional blood sample perform sub-set patient find invasive candidiasis . The sensitivity , specificity , PPV , NPV biomarker assay determine biomarker assay . No PHI store database limit blood draw ( 3 ml/kg 8 week period ) adhere .</brief_summary>
	<brief_title>BIOPIC : Fungal Biomarkers Diagnosis Response Therapy Pediatric Candidemia</brief_title>
	<detailed_description>This study create international multi-center cohort child new clinical concern infection ICU . The study collect 23 US sit 18 International site ; site may add future . Sites use part International Pediatric Fungal Network ( PFN ; www.ipfn.org ) . We plan enroll total 500 high-risk inpatient course four year . The study plan prospectively enroll pediatric ICU patient high-risk develop invasive candidiasis four year period . The study duration per subject 14 day blood collection 30 day data collection medical record . Additionally , inpatient clinical data 14 day prior first blood draw collect . The subject participate study 30 day day first blood draw collect . For first aim , study assemble prospective cohort pediatric patient high-risk develop invasive candidiasis . Blood sample biomarker test obtained time patient clinical indication blood culture attainment . To accomplish second aim , additional blood sample perform sub-set patient find invasive candidiasis . For third aim , leftover blood sample follow biomarker test consent participant store biobank . This biobank use examine future , currently undeveloped , biomarker assay effort reduce time diagnosis invasive candidiasis .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<criteria>1 . Males females age &gt; 120 day &lt; 18 year 2 . Have least one follow condition : admit nonneonatal ICU underlie disease transfer imminently nonneonatal ICU underlie disease gastrointestinal insufficiency ( eg . chronic shortgut syndrome ) admit anywhere hospital hematological malignancy ( limited AML , ALL , nonHodgkin 's lymphoma myelodsyplastic syndrome ) admit anywhere hospital solid tumor malignancy admit anywhere hospital solid organ transplant admit anywhere hospital hemopoeitic stem cell bone marrow transplant admit anywhere hospital aplastic anemia admit anywhere hospital 3 . Have ≥ 1 central catheter ( arterial venous ) 4 . Have ≥ 1 blood culture drawn clinical concern infection time enrollment 5 . Clinician initiate and/or change systemic antimicrobial therapy time enrollment 6 . Parental/guardian permission ( informed consent ) , appropriate , child assent . 7 . For Aim 2 : Each AND positive blood culture Candida spp . turn positive day 0 day +14 . 1 . Diagnosis invasive fungal infection within previous 30 day 2 . Previous inclusion study 3 . Weight &lt; 4 kg ( Due constraint 3 ml/kg blood drawn 8 week period ) . Subjects fall 4 kg study period blood draw occur 0.75 ml/kg blood drawn time . 4 . Patient receive empiric antifungal therapy prolong neutropenia fever start prior time blood culture 5 . If blood culture obtain antiinfectives added/changed part local protocol dictate clinical concern infection</criteria>
	<gender>All</gender>
	<minimum_age>120 Days</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>IPFN</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Fungal</keyword>
	<keyword>Biomarker Assays</keyword>
	<keyword>Candida</keyword>
	<keyword>Pediatric ICU patient</keyword>
</DOC>